Create a Profile

I accept digital forms of communication(Required)
Hidden
Hidden
This field is for validation purposes and should be left unchanged.

FIND A TRIAL NEAR YOU

No location found for this Zip Code

-- or --

No location found for this Location

FIND A TRIAL NEAR YOU

No location found for this Zip Code

-- or --

No location found for this Location

Idiopathic Pulmonary Fibrosis Study

If you or a loved one are living with Idiopathic Pulmonary Fibrosis (IPF) and not yet started treatment, consider participating in a new study at Accel Research Sites.

By participating, you can help doctors learn more about a new investigational medication for IPF.

If you or a loved one meet the following conditions, please contact us today to learn more:

  • Age 40 years or above
  • Diagnosed with IPF
  • Have never been treated for IPF or have been treated with nintedanib (Ofev® or Vargatef®) for less than 6 full months
  • Have never taken pirfenidone (Esbriet®, Pirespa®, or Etuary®)

Those who qualify for the study will receive:

  • Study-related care at no cost
  • Compensation for study-related participation

Create a Profile

I accept digital forms of communication(Required)
Hidden
Hidden
This field is for validation purposes and should be left unchanged.

Get In Touch Mobile

I accept digital forms of communication(Required)
This field is for validation purposes and should be left unchanged.

Study Locations

Accel Research Sites | NeuroStudies
755 Commerce Drive
Decatur, Georgia 30030
Accel Research Sites | Deland
860 Peachwood Drive
DeLand, Florida 32720